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Abstract. 
 
The death-effector domain (DED) is a criti-
cal protein interaction domain that recruits caspases 
into complexes with members of the TNF-receptor su-
perfamily. Apoptosis can also be induced by expressing 
certain DED-containing proteins without surface re-
ceptor cross-linking. Using Green Fluorescent Protein 
to examine DED-containing proteins in living cells, we 
show that these proteins cause apoptosis by forming 
novel cytoplasmic filaments that recruit and activate 
pro-caspase zymogens. Formation of these filaments, 
which we term death-effector filaments, was blocked by 
coexpression of viral antiapoptotic DED-containing 
proteins, but not by bcl-2 family proteins. Thus, forma-
tion of death-effector filaments allows a regulated in-
tracellular assembly of apoptosis-signaling complexes 
that can initiate or amplify apoptotic stimuli indepen-
dently of receptors at the plasma membrane.
 
A
 
ctivation
 
 of caspases, a family of cysteine proteases,
is an essential step in many forms of apoptosis
(Nicholson and Thornberry, 1997). Caspases have
been found in many multicellular organisms, and their role
in programmed cell death is highly conserved. Among cys-
teine proteases, caspases are unique in requiring aspartate
at the cleavage site in their substrates. Caspase activation
occurs through the limited proteolysis of a proenzyme
form. Cleavage of the proenzyme occurs at aspartates,
suggesting that autoprocessing or processing by other
caspases plays a prominent role in generating the active
enzyme. Each precursor contains a prodomain, a large
subunit, and a small subunit. Evidence suggests that the
fully active enzyme is a tetramer containing two large and
two small subunits, and lacking the prodomain. The sub-
strates of the active enzyme are molecules whose cleavage
is believed to be necessary for orderly disintegration of the
cell (Rosen and Casciola-Rosen, 1997). In addition, cer-
tain caspases, such as caspase 1, play an important role in
cytokine processing (Fantuzzi et al., 1997; Ghayur et al.,
1997).
A principal means of caspase activation is through death
domain–containing transmembrane receptors such as
CD95/FAS/APO-1 or other members of the tumor necro-
sis factor receptor (TNFR) superfamily. The death domain
is a 60–amino acid portion of the cytoplasmic tail neces-
sary for apoptosis signaling. Although widely expressed,
these receptors have been best characterized in the im-
mune system, where they play a critical role in lymphocyte
homeostasis, tolerance, and immune protection (Chin-
naiyan and Dixit, 
 
1997;
 
 
 
Lenardo et al., 1995; Nagata and
Golstein, 1995). Both B and T lymphocytes are regulated
by Fas-induced apoptosis. Mice or humans with genetic
defects in the Fas death receptor can develop lymphopro-
liferation and severe humoral autoimmunity
 
 
 
(Fisher et al.,
1996; Rieux-Laucat et al., 1995; Singer et al., 1994). During
immune responses, cytotoxic T cells can induce target cell
lysis through Fas/Fas ligand interactions, and can also di-
rectly activate caspases in target cells by releasing perforin
and granzyme B (Chinnaiyan et al., 1996; Kagi et al., 1994;
Schroter et al., 1995). Moreover, there are other forms of
nonreceptor apoptosis involving caspase action, implying
that additional as yet undiscovered cytoplasmic mecha-
nisms of caspase activation must exist.
Apoptosis induction by the TNFR family receptors is
due to formation of a protein-signaling complex that in-
volves the physical association of caspases followed by
their activation (Kischkel et al., 1995; Medema et al.,
1997). Since no other posttranslational modification has
been shown to be required for apoptotic signaling, the oli-
gomerization state of the receptor and associated proteins
appears to be the critical factor in activating the signaling
cascade. In the case of Fas, the interaction and activation
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of caspase-8 (FLICE/MACH
 
a
 
1/MCH5) is thought to be
the first step in a cascade of caspase activation. (Boldin et al.,
1995; Medema et al., 1997)
 
.
 
 The caspase-8 proenzyme con-
tains a long amino-terminal prodomain of 209 amino acids,
followed by the coding sequences for the p18 and p11 sub-
units of the active enzyme. Activation of this pivotal
caspase is a consequence of oligomerization and autopro-
cessing after recruitment to Fas. The apoptosis-signaling
complex assembles very rapidly after receptor trimeriza-
tion following Fas ligand engagement. FADD (MORT1),
an adapter molecule that contains a death domain in its
COOH terminus, homotypically associates with the Fas
death domain (Kischkel et al., 1995; Medema et al., 1997).
The crucial interaction for caspase recruitment, however,
is a second homotypic interaction between the NH
 
2
 
 termi-
nus of FADD and the prodomain of caspase 8 through a
conserved 80–amino acid domain termed the death effec-
tor domain (DED).
 
1
 
The DED was originally defined by the minimal portion
of the FADD molecule capable of inducing apoptosis in a
transient transfection assay (Chinnaiyan et al., 1995). The
long prodomain of caspase-8 harbors two highly homolo-
gous DED domains, termed DED-A and DED-B (Boldin
et al., 1995; Muzio et al., 1996). Yeast two-hybrid experi-
ments have shown that the DED domains are essential for
binding the caspase-8 prodomain to FADD. When ex-
pressed in certain cell types, the caspase 8 prodomain can
potently induce apoptosis without any requirement for
FAS cross-linking (Boldin et al., 1995; Muzio et al., 1996).
How the DED initiates this nonreceptor form of death is
unknown.
Paradoxically, DEDs have also been identified recently
in several viral proteins, such as the molluscum contagio-
sum virus MC159 protein or the equine herpes virus type 2
E8 protein, that block apoptosis induced by Fas cross-link-
ing. Overexpression of these proteins, termed FLIPs
(FLICE inhibitory proteins), does not produce apoptosis,
but instead interferes with Fas signaling by inhibiting the
DED-mediated interaction of FADD and Caspase-8 (Ber-
tin et al., 1997; Hu et al., 1997; Thome et al., 1997). In addi-
tion, a cellular homologue of Caspase-8 harboring tandem
DEDs but a nonfunctional caspase domain has been iden-
tified. Overexpression of this molecule, termed c-FLIP (or
variously: Casper, MRIT, FLAME, Usurpin, or I-FLICE),
or its DED-containing prodomain, can induce apoptosis
when highly overexpressed, or can block Fas-induced apop-
tosis at lower expression levels (Han et al., 1997; Hu et al.,
1997; Irmler et al., 1997; Rasper et al., 1998; Shu et al.,
1997; Srinivasula et al., 1997). Thus, proteins containing
the same critical protein interaction domain can have pro-
and antiapoptotic effects.
What could account for the divergent behavior of pro-
teins bearing the DED domain? Since subcellular localiza-
tion is often important for regulating signaling molecules
(Mochly-Rosen, 1995), we examined the localization of
various DED proteins using Green Fluorescent Protein
and other epitope tags. We find that apoptosis triggered by
the DED protein motif is in all cases associated with the
formation of intracellular filaments, which we term death-
effector filaments (DEF). Procaspases are efficiently re-
cruited to these structures. Viral DED-containing proteins
that block Fas-induced apoptosis lack the ability to form
these filaments, and can antagonize apoptosis by inhibiting
formation of the DEF. These data provide a mechanism
for the initiation of apoptosis by DED-containing proteins
such as FADD, and show that assembly of apoptosis-sig-
naling complexes can occur intracellularly as well as at the
plasma membrane.
 
Materials and Methods
 
Vectors, Plasmid Construction, and Reagents
 
Caspase-8-GFP fusion proteins were constructed using Pwo polymerase
to amplify fragments of a pCMV-Caspase-8 plasmid whose sequence had
been confirmed to be identical to the published MACH
 
a
 
1/FLICE se-
quences. Primers were designed to contain unique sites that were ligated
into pEGFPN1 (CLONTECH Laboratories, Inc., Palo Alto, CA) cut with
compatible restriction enzymes. pEGFPN contains the enhanced GFP se-
quence with multiple point mutations as well as codon optimization for
mammalian expression. Caspase-8 103-209 (DED-B) and 210-479 (CD)
were generated using additional 5
 
9
 
 primers containing unique BamHI
sites. FADD 1-79 (DED) and 80-220 (DD) were cloned using an endoge-
nous SalI site at the AA 79 codon and unique 5
 
9
 
Hind III and 3
 
9
 
 BamHI
sites in pcDNA FADD (a gift from Dr. Vishva Dixit, Genentech Inc.,
South San Francisco, CA). FADD 1-79 was cloned into pEGFP N3, and
FADD 80-220 was cloned into the COOH-terminal multiple cloning site of
pEGFP C2. The C360S mutation was introduced using the QuickChange™
kit (Stratagene, La Jolla, CA) with appropriate mutagenesis primers, and
candidate clones were screened by automated fluorescent sequencing. HA-
tagged MC159 and E8 fusion protein constructs were made by amplifying
the coding sequences of these proteins with a 5
 
9
 
 oligonucleotide contain-
ing an EcoRI site and the HA tag sequence (YPYDVPDYA) in frame with
the first methionine codon, and a 3
 
9
 
 oligonucleotide containing the
COOH terminal sequences followed by an XbaI site. Digested PCR prod-
ucts were cloned into EcoRI/XbaI-digested pCI vector (Promega Corp.,
Madison, WI). Pbcl-2CMV and pBcl-x CMV were gifts from Dr. Charles
Zacharchuk. Plasmids were prepared for transfection with the Monster™
prep system (Bio 101, La Jolla, CA). zVAD FMK was obtained from En-
zyme System Products (Livermore, CA) or Kamiya Biochemical Co. (Se-
attle, WA). DEVD-Rhodamine (PhiPhiLux) was obtained from Oncoim-
munin (College Park, MD). HeLa and 293T cell lines were obtained from
American Type Culture Collection (Rockville, MD). The Jurkat Tag cell
line expressing the SV40 large T antigen was a gift from Dr. Gerry Crab-
tree (Stanford University, Stanford, CA).
 
Transient Transfection and Apoptosis Assays
 
1–2 
 
3 
 
10
 
7 
 
Jurkat Tag cells were transfected with 20 
 
m
 
g of each DNA con-
struct using a BTX EC600 electroporator (260V, 1040 
 
m
 
F, 720 Ohm). Jur-
kat Tag cells stably express the SV40 large T antigen, which allows the
transfected plasmids containing the SV40 ori to replicate, increasing pro-
tein expression by 
 
z
 
50%. Apoptosis induced by caspases or Fas cross-
linking was not affected by SV40 T antigen expression. In control experi-
ments, 50 
 
m
 
M zVAD fmk was added directly after transfection. 16 h later,
cells were harvested and analyzed in parallel for apoptosis by two separate
methods using flow cytometry. Phosphaditylserine exposure on the outer
leaflet of the plasma membrane was quantitated by incubating 2.5–5 
 
3 
 
10
 
5
 
cells with 1:50 diluted Annexin-V Cy3 (CLONTECH Laboratories) ac-
cording to the manufacturer’s instructions. DEVD cleavage was assayed
by incubating 1 
 
3
 
 10
 
6 
 
transfected cells with 50 
 
m
 
l of PhiPhiLux DEVD-
rhodamine substrate (Oncoimmunin) and 5 
 
m
 
l FCS for 1 h at 37
 
8
 
C. This
substrate is relatively nonfluorescent due to quenching interactions be-
tween the two rhodamine molecules on either side of the peptide until
cleavage by caspases occurs. Generation of fluorescent cleavage products
has been shown to be specific for caspases (Pierre Henkart, personal com-
munication). Cells were washed 1
 
3
 
 with FACS buffer and analyzed on a
FACSscan™ cytometer (Becton Dickinson & Co., Franklin Lakes, NJ).
To exclude necrotic cells that may be nonspecifically positive for Annexin
 
1.
 
 Abbreviations used in this paper
 
: DED, death-effector domain; DEF,
death-effector filaments; FLIP, FLICE (caspase-8) inhibitory proteins; in-
hibitory proteins; GFP, green fluorescent protein; v-FLIP, viral DED-con-
taining proteins. 
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or DEVD cleavage, only cells that fell into a viable FSC/SSC gate were
quantitated. In parallel experiments, these cells were found to exclude
propidium iodide uniformly. Thus, the percentages obtained, although
specific for apoptosis, are indicative of early apoptotic cells only, and are
probably an underestimate of the total percentage of cells induced to un-
dergo apoptosis in the culture. HeLa cell apoptosis was quantitated by vi-
sual inspection of Green Fluorescent Protein (GFP)-expressing cells with
an inverted fluorescent microscope. Cells with a shrunken or blebbed ap-
pearance were scored as apoptotic. Counts were done in duplicate, and at
least 100 cells per data point were counted.
 
Immunofluorescence
 
293T or HeLa cells were grown on glass coverslips (pretreated with 1%
poylysine K for 293T cells), and expression vectors were transfected using
the Superfect™ reagent (Qiagen Inc., Chatsworth, CA) according to the
manufacturer’s instructions. 16–24 h later, cells were labeled with 1 
 
m
 
g/ml
Hoechst 33342 for 30 min at 37
 
8
 
C, and were fixed with 100% methanol at
 
2
 
20
 
8
 
C for 15 min. Coverslips were then washed with PBS and blocked in
IFA buffer (PBS with 0.1% BSA and 0.01% Tween-20). Primary mono-
clonal antibodies were added at 1 
 
m
 
g/ml in IFA buffer for 1 h, and second-
ary antibodies were added for 30 min with 2 washes between each step.
Sources of antibodies were antitubulin and antivimentin (Amersham
Corp., Arlington Heights, IL), anti Bcl-x (Trevigen, Gaithersburg, MD),
anti-FADD (Signal Transduction Labs, Lexington, KY), and anti-AU1
and HA.11 antihemagglutinin (Berkeley Antibody Co., Inc., Richmond,
CA). After rinsing briefly in H
 
2
 
O, coverslips were mounted with Fluoro-
mount G (Electron Microscopy Sciences). For mitochondrial staining, 25
nM Mitotracker Red (OR R7512; Molecular Probes, Inc., Eugene, OR)
was added to cultures for 15 min at 37
 
8
 
C before fixation. Cells were exam-
ined with an Axiophot microscope (63
 
3
 
 or 100
 
3
 
 objectives; Carl Zeiss
Inc., Thornwood, NY), and images were acquired with a CCD camera
(Princeton Digital Instruments, Princeton, NJ) and appropriate filters and
then processed with Adobe Photoshop software.
 
Subcellular Fractionation and Western Blotting
 
Subconfluent six-well dishes of 293T cells were transfected with 4 
 
m
 
g of
the indicated constructs using Superfect™ (Stratagene) according to the
manufacturer’s instructions. 50 
 
m
 
M zVAD FMK was added when active
caspase-containing constructs were used. 24 h after transfection, 293T
cells were lysed for 30 min on ice in buffer containing 140 mM NaCl, 10
mM Tris (pH 7.2), 2 mM EDTA, 1% NP-40, complete protease inhibitor
mix (Boerhinger Mannheim Corp., Indianapolis, IN), and 10 mM iodoace-
tamide. The detergent-insoluble fraction was pelleted by centrifugation at
14,000 rpm in an Eppendorf centrifuge for 10 min. Pellets were washed
three times with lysis buffer before boiling in SDS sample buffer. Samples
containing lysates and pellets from equal cell numbers were electropho-
resed on 4–20% Tris/glycine/SDS gels and blotted onto nitrocellulose us-
ing a semidry transfer apparatus. Blots were blocked with 5% nonfat dry
milk for 30 min, and were probed with 1:1,000 dilution of a mixture of
anti-GFP mAb (Boerhinger Mannheim Corp.) or 1:1,000 diluted anti-HA
mAb (Berkeley Antibody Co., Inc.) followed by 1:10,000 dilution of don-
key anti–mouse HRP (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA), with three washes after each incubation. Incubations and
washes were performed with 0.05% PBS TritonX-100. Bands were imaged
with SuperSignal™ HRP substrate (Pierce Chemical Co., Rockford, IL).
 
Results
 
The DED Domains From FADD and Caspase-8 
Can Induce Apoptosis Independently of Fas Signaling
 
To study the intracellular location of DED-containing
proteins, full-length and truncated versions of FADD and
Caspase-8 were fused with GFP (Fig. 1). GFP allowed us
to examine the subcellular localization of these proteins in
living cells under various conditions. Transient transfec-
tion of the GFP-tagged version of full-length caspase-8 ef-
ficiently induced morphological changes, consistent with
apoptosis in HeLa and Jurkat cell lines (Figs. 1 and 2, wild-
type). However, fusions of GFP with the caspase-8 pro-
domain, containing the two tandem DEDs and FADD
containing a single DED, also induced cell death (Fig. 1).
Because FADD and the caspase-8 prodomain contain no
caspase moiety, we wanted to determine if they triggered
caspase activation and apoptosis. We confirmed that DED-
Figure 1. Structure and func-
tion of fusion proteins used in
this study. The hatched bars
denote DED, and the check-
ered bars denote the death
domain (DD) in FADD ho-
mologous to that in death
domain–containing receptors.
Processing sites at aspartate
residues (D) and the active-site
cysteine (C360*) are shown.
HA denotes the influenza he-
magglutinin epitope tag. p18
and p11 are the large and small
subunits of the mature pro-
cessed caspase-8 enzyme. The
numbers indicate the amino
acids at the junction of the
GFP fusion proteins, num-
bered  according to the human
MACH  a1 and FADD se-
quences available on Genbank.
The 1 and 2 symbols indicate
whether transfection of the mol-
ecule in HeLa or Jurkat cells in-
duced apoptosis (.20%) or fila-
ment formation (.50%). CD,
caspase domain. 
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transfected cells were dying via apoptosis by the morpho-
logical appearance of Hoechst-stained nuclei (data not
shown), and by exposure of phosphaditylserine (PS) as de-
tected by Annexin-V surface staining (Fig. 2, 
 
A
 
 and 
 
B
 
). To
demonstrate caspase activation directly in GFP-expressing
cells, we used a new cell-permeable DEVD–rhodamine
caspase substrate that exhibits red fluorescence only after
cleavage (Packard et al., 1996). Flow cytometry after expo-
sure to this substrate revealed that cells expressing the
GFP-DED proteins fluoresced red, indicating proteolysis
by activated caspases. Flow cytometry of the intact cells
revealed that caspase activation is tightly regulated by the
intracellular concentration of DED proteins. Above a
threshold value of fluorescence, which is proportional to
the amount of protein expressed, both PS exposure and
DEVD-rhodamine fluorescence were observed, indicating
that apoptosis commences in most cells (Fig. 2 
 
A
 
, 
 
bottom
 
).
Control experiments confirmed that endogenous caspase
activation was involved, since death was prevented by the
inhibitor zVAD-fmk (Fig. 2 
 
B
 
).
 
DED Proteins Form Cytoplasmic Filaments Associated 
with Apoptosis
 
When we examined cells expressing GFP fusion proteins
with caspase-8, FADD, and the various truncation mu-
tants under the microscope, we found two dramatically
different patterns of fluorescence distribution (Fig. 3). The
first pattern, seen with the full-length caspase-8 protein,
was a diffuse distribution throughout the cytoplasm (C360S;
Fig. 3 
 
A, top left
 
 and data not shown). A similar diffuse
pattern was observed when the caspase domain alone was
expressed (CD; Fig. 3 
 
A, middle left
 
). In these analyses, apop-
tosis was inhibited with zVAD-fmk or by using the C360S
active site mutant. Without blocking apoptosis, we ob-
served packaging of the caspase-GFP proteins into apop-
totic blebs in dying cells (data not shown).
The second pattern, illustrated using the DED-contain-
ing prodomain of caspase-8 fused to GFP, was a distinctive
cytoplasmic filament network (DED-AB; Fig. 3 
 
A
 
, 
 
top
right
 
). Greater than 90% of the fluorescence was concen-
trated into what appeared to be a small number of inter-
connecting filaments with a perinuclear localization, some-
times appearing as a cage or lariat structure around the
nucleus (see Fig. 7). The filaments were variable in thick-
ness, and could be clearly identified as round when seen
on end with confocal microscopy (data not shown). The
filaments were observed in unfixed cells in culture as well
as after methanol or formaldehyde fixation, and did not
break down or reorganize in mitotic cells (data not
shown). When observed over time, the filament assem-
blies first formed in healthy-appearing cells, and did not
depend on caspase activity since zVAD-fmk treatment did
not prevent their formation. In fact, zVAD-fmk promoted
formation of a more complex filamentous network (Fig. 3
 
B
 
, 
 
right
 
). To show that GFP was not required for the for-
mation of these structures, the filaments were also visual-
ized with conventional immunostaining using an AU-1
epitope tag (Fig. 3 
 
A
 
, middle right). Unlike many other
proteins that are typically packaged into apoptotic blebs,
the filaments remained intact in a collapsed configuration
in the perinuclear cytoplasm of apoptotic cells (Fig. 3 
 
B
 
, left).
To determine if filament formation is a general property
of apoptosis-inducing DED-domain proteins, we per-
formed similar experiments with FADD. A GFP fusion
protein with the death domain–containing COOH termi-
Figure 2. Apoptosis induc-
tion by DED and caspase
proteins. (A) FACS profiles
demonstrating apoptosis in-
duced by transient transfec-
tion of the caspase-8 pro-
domain. Jurkat Tag cells
(expressing the SV40 Tag for
higher expression of replicat-
ing plasmids) were tran-
siently transfected with the
indicated GFP fusion protein
constructs. 16 h after trans-
fection, cells were analyzed
by flow cytometry for An-
nexin-V or DEVD-rhodamine
staining (y-axis) and GFP
fluorescence (x-axis) as de-
scribed in the experimental
procedures. Percentages in
each quadrant are shown by
the numbers in the diagram
at the top right corner of
each plot. The apoptotic cells
that are GFP-negative but Annexin-V–positive are nonspecifically induced by electroporation. (B) Summary of Annexin-V binding and
DEVD rhodamine cleavage induced by the different fusion proteins and inhibition by zVAD FMK. Jurkat cells were transfected with
20 mg of the indicated constructs and analyzed by flow cytometry 16 hours after transfection. Percentages are the percentage of GFPhi
cells gated as in A, positive for DEVD-rhodamine or Annexin-V binding. Data are representative of at least three independent transfec-
tion experiments for each data point. Constructs that produced ,20% apoptotic GFP-positive cells were considered to be negative for
apoptosis. 
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nal of FADD, which does not induce apoptosis, was dis-
persed throughout the cytoplasm (Fig. 3 
 
C
 
, 
 
top left
 
). How-
ever, the full-length GFP-FADD fusion protein that contains
a single DED and induces apoptosis, formed filaments
similar to the caspase-8 prodomain (Fig. 3 
 
C
 
, bottom
right). The minimal 79–amino acid DED domain of FADD
that also induces apoptosis, produced shorter, more nu-
merous filaments with some diffuse staining, especially in
the more viable cells (Fig. 3 
 
C
 
, 
 
top right
 
). The FADD fila-
ments could also be detected by immunostaining in the ab-
sence of GFP or any epitope tag revealing that these struc-
tures form as an intrinsic property of the proteins (Fig. 3
 
C, bottom left
 
). These data suggest a strong correlation be-
tween filament formation and apoptosis induction.
When we tested the A and B DEDs of caspase-8 indi-
vidually, we found additional evidence associating apopto-
sis with filament formation. The DED-B fusion with GFP
formed fine filaments with a beads-on-a-string morphol-
ogy (Fig. 3 
 
A
 
, 
 
bottom right
 
) and induced apoptosis (Fig. 2
 
B
 
). By contrast, the DED-A-GFP protein neither formed
filaments nor induced apoptosis (Fig. 3 
 
A, bottom left
 
). It is
notable that although full-length caspase-8 induces apop-
tosis and contains the filament-forming DED-B, it does
not assemble into filaments (Fig. 3 
 
A, top left
 
). Overex-
pression of the full-length or the caspase domain of
caspases initiates apoptosis by direct autoactivation of its
enzymatic function, and thus may bypass the requirement
for filament formation (Nicholson and Thornberry, 1997).
In the full-length caspase-8 protein, the domain that ini-
tiates filament formation may be shielded by the caspase
domain. Thus, the DED-A and DED-B motifs in the pro-
domain of caspase-8 are functionally distinct, and support
the conclusion that filament assembly is required for the
lethal effect of DEDs. We therefore propose the name
death-effector filament (DEF) for these apoptosis-associ-
ated cytoplasmic structures.
Figure 3. Localization and solubility of DED-containing proteins. (A and C) HeLa cells were transiently transfected with 0.5–1 mg of
the indicated portions of Caspase-8 (A) and FADD (C) fused to GFP in the presence of 50 mM zVAD-FMK to inhibit apoptosis. Cells
were selected for photography 16–24 h after transfection. The blue counterstain indicates nuclei. B shows the predominantly apoptotic
morphology of cells transfected with caspase-8 DED-AB (left), which can be inhibited by adding of 50 mM zVAD-FMK at the time of
transfection (right). The middle right photograph in A and bottom left in C are conventional immunofluorescence pictures of represen-
tative cells transfected with AU-1-epitope–tagged Caspase-8 prodomain stained with anti-AU1 and untagged FADD full-length protein
stained with anti-FADD mAb, followed by Texas Red–conjugated anti-mouse IgG. (D and E) Solubility of DED proteins in detergent
correlates with their morphological appearance. 1% NP40 lysate supernatants (S) and pellets (P) from equal numbers of transfected
cells were separated on 4–20% gradient polyacrylamide gels and blotted with anti-GFP mAbs. In each case, the top band corresponds to
the predicted size of the fusion protein, and lower bands represent degradation products that were variably seen in different experi-
ments. Similar results were obtained with 1% Triton-X100 detergent lysates. Fusion proteins of the correct predicted sizes were found
for the other Caspase-8 fusion proteins (not shown). 
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DEFs Have Solubility Properties of the Cytoskeleton, 
but Do Not Colocalize With Other Known Cytoskeletal 
Elements or Mitochondria
 
Because DEFs display a morphology similar to that of cy-
toskeletal filaments, we examined the solubility properties
of the GFP fusion proteins by extracting transfected cells
with various detergents. Polymerized cytoskeletal proteins
are uniformly insoluble in nonionic detergents (Aamodt
and Williams, 1986; Steinert et al., 1982). Filament forma-
tion by the DED proteins led to a similar insolubility in
1% NP-40 or Triton X-100 (Fig. 3, 
 
D
 
 and 
 
E
 
). The DEF
formed by the caspase 8 DED-AB was almost exclusively
detergent-insoluble (Fig. 3 
 
D
 
, lanes 
 
1
 
 and 
 
2
 
). Conversely,
the WT caspase-8 protein was predominantly in the solu-
ble fraction, corresponding to its diffuse intracellular dis-
tribution (Fig. 3 
 
D
 
, lanes 
 
3
 
 and 
 
4
 
). FADD and its deriva-
tives behaved similarly. The death domain of FADD,
which does not induce apoptosis and is diffuse throughout
the cytoplasm, was fully detergent-soluble (Fig. 3 
 
E
 
, lanes
 
1
 
 and 2). The FADD DED domain, which forms shorter
filaments with some diffuse distribution, was partially sol-
uble (Fig. 3 E, lanes 3 and 4). The full-length FADD pro-
tein, which exclusively localized to long filaments, was al-
most fully insoluble in NP-40 (Fig. 3 E, lanes 5 and 6). The
fact that the full-length FADD protein formed more ex-
tensive filaments and was more insoluble than the DED
alone suggests that additional domains in the FADD pro-
tein may facilitate its aggregation into DEFs.
We also examined the relationship of death-effector fil-
aments to known cytoskeletal structures by double-label-
ing experiments. We found that the DEF formed by the
caspase-8 prodomain was independent of either microtu-
bules or intermediate filaments (Fig. 4). There was some
resemblance to the vimentin network, including identical
perinuclear localization and hyperaggregation with colchi-
cine (data not shown), but little direct overlap was seen.
Staining with a monoclonal antibody that recognizes all
types of intermediate filaments (Pruss et al., 1981) or
rhodamine-phalloidin for polymerized actin also showed
no colocalization with DEFs (data not shown). Since
caspases have been reported to coprecipitate with mito-
chondrially located bcl-2 family proteins (Chinnaiyan et al.,
1997; Han et al., 1997), and mitochondria can have fila-
ment-like patterns in some cells, we also examined DED-
transfected cells with mitochondrial dyes. No overlap was
seen between the pattern of mitochondrial staining and
the DEF. (Fig. 4, right). Thus, the DEF is a novel cytoskel-
eton-like structure that could result either from self-
assembly of DEDs or their binding to an as-yet unidenti-
fied cytoskeletal element.
Pro-caspase-8 is Efficiently Recruited to the DEF
DED-containing proteins can aggregate and activate cas-
pase-8 at the plasma membrane during Fas-stimulated apop-
tosis. We therefore tested the hypothesis that the DEF
may function similarly in the cytoplasm, and may cause
apoptosis by the recruitment and activation of endogenous
pro-caspases. We cotransfected the GFP-tagged full-
length caspase-8 molecule that is normally diffuse in the
cell with the filament-forming FADD or the caspase-8
Figure 4. Comparison of
DEFs with other cellular
structures and costaining
with anti-Caspase-8 antisera.
HeLa cells (b Tubulin) or
293T cells (Vimentin and Mi-
totracker Red) were trans-
fected with 1 mg of the
Caspase-8 DED-AB GFP
construct, and then fixed and
prepared for immunofluores-
cence analysis with antitubu-
lin or antivimentin antibodies
followed by Texas-Red–con-
jugated secondary antibodies
as described in experimental
procedures. For mitochon-
drial staining, coverslip cul-
tures were preincubated with
25 nM of Mitotracker Red
7512 before fixation. The top
row shows the pattern of
staining with these reagents
in the red channel; the mid-
dle row show the pattern of
DED-AB GFP expression,
and the lower row shows the
overlay of the two channels,
with blue indicating the
Hoechst-stained nuclei. Over-
lapping fluorescence would
be yellow.Siegel et al. Death-effector Filaments 1249
prodomains. Because apoptosis distorts the DEF, we used
the C360S inactive version of caspase 8 and added the
caspase inhibitor zVAD-fmk. We found that expression of
the caspase 8 prodomain (visualized by an AU-1 tag; Fig. 5
C) caused the normally diffuse expression pattern of the
caspase 8-C360S-GFP molecule to relocalize to the DEF
(Fig. 5, A, C, and E). The relocalization was remarkably
efficient. The overlay picture (Fig. 5 E) reveals little resid-
ual green fluorescence, indicating that essentially all of the
caspase-8 has translocated to the DEF. Recruitment of
caspase-8 required the DEDs, since the caspase domain
only, without the prodomain (caspase 8 CD), did not relo-
calize to the DEF (Fig. 5, B, D, and F). FADD also effi-
ciently recruited caspase-8 into DEFs (data not shown).
These data are consistent with yeast two-hybrid experi-
ments in which the caspase-8 prodomain and FADD were
found to interact with each other and with full-length
caspase-8 (Boldin et al., 1995; L. Zheng and M.J. Lenardo,
unpublished data). Taken together, these findings suggest
that the cytoplasmic mechanism for nonreceptor apoptosis
induced by DED proteins involves recruitment of pro-
caspases into the DEF. To verify this hypothesis, it was im-
portant to inhibit DEF formation to determine whether
this could prevent apoptosis.
Viral-FLIP Proteins Block DEF Formation and
Cell Death Induced by Proapoptotic DED Proteins
We and others have shown that viral DED-containing pro-
teins (v-FLIPs) can block apoptosis induced by multiple
death receptors, rather than stimulating apoptosis them-
selves (Bertin et al., 1997; Hu et al., 1997; Thome et al.,
1997). We therefore tested the ability of these viral pro-
teins to form death-effector filaments. The patterns of the
v-FLIP proteins MC159 and E8 were examined in HeLa
cells using anti-HA antibodies directed against amino ter-
minal epitope tags. By immunofluorescence, both proteins
were diffusely distributed throughout the cytoplasm, with
a small amount of nuclear staining (Fig. 6 A). Thus, nei-
ther protein formed DEFs, and as we and others have pre-
Figure 5. Recruitment of
procaspase-8 into DEF.
HeLa cells were cotrans-
fected with 1.5 mg of AU1-
tagged caspase-8 prodomain
molecule and 0.5 mg of GFP-
tagged full-length caspase-8
C360S (a, c, and e) or the
caspase domain only (amino
acids 210–479) of caspase-8
(b, d, and f). 50 mM zVAD-
fmk was added to inhibit
apoptosis. Coverslips were
incubated with anti-AU1,
followed by Texas-Red anti-
mouse IgG. Green fluores-
cence is shown in a and b, red
is shown in c and d, and the
overlay of the two panels is
shown in f and g. The overlap
of AU1 and GFP is shown in
yellow. In the left panels, clear
overlap of the caspase-8 and
DED signals are seen, show-
ing recruitment of Caspase-8
to the DEF. In the right pan-
els, the cell at the top right
expresses high levels of the
DED in red, but a diffuse pat-
tern staining is still seen with
Caspase-8 caspase domain
(CD), indicating that re-
cruitment to the DED occurs
through DED–DED interac-
tions.The Journal of Cell Biology, Volume 141, 1998 1250
viously reported, neither protein induced apoptosis. West-
ern blot analysis showed that HA-tagged MC159 and E8
were completely soluble in nonionic detergents (Fig. 6 B).
These data suggest that v-FLIPs do not cause apoptosis
because they cannot form the DEF, and therefore cannot
recruit and activate endogenous caspases in the cytoplasm.
Since v-FLIPs interact with DED-containing proteins
(Bertin et al., 1997; Hu et al., 1997; Thome et al., 1997), we
were able to ask whether this interaction could block
DED-induced apoptosis by affecting the DEF. In our ex-
perimental system, the viral MC159 protein could suppress
apoptosis induced by either FADD or the prodomain con-
taining DEDs A and B from caspase 8 (Fig. 7 B). When
cells coexpressing the v-FLIP and the GFP-tagged cas-
pase-8 prodomains or FADD DED were examined micro-
scopically, we observed shorter or absent filaments, and
the cell morphology was not apoptotic (Fig. 7 A, left). The
E8 v-FLIP had similar effects (data not shown). Our cell
transfection assay also generated some cells that only take
up and express one plasmid, thereby allowing us to exam-
ine cells in the same sample that expressed DED protein
in the absence of the v-FLIP. These cells exhibited DEFs
with a collapsed morphology, indicating that apoptosis was
occurring (Fig. 7 A, left bottom, green filaments). From
these data we conclude that the DEF is essential for the
nonreceptor cytoplasmic mechanism of apoptosis caused
by DEDs, and that v-FLIPs abrogate this mode of death
by blocking DEF formation.
To gain additional insight into the regulation of apopto-
sis caused by the DEF, we asked whether blocking apopto-
sis with bcl-2 family proteins could disrupt the DEF. Bcl-x
potently blocked apoptosis induced by transfection of
FADD and the caspase-8 prodomain (Fig. 7 B). However,
examination of cotransfected cells did not reveal any dis-
ruption of the death-effector filaments (Fig. 7 A, right).
Taken together, these data demonstrate that the v-FLIPS
and Bcl-x block apoptosis induced by DEFs, but exert
their effects through distinct mechanisms.
Discussion
In these studies we have characterized a cytoplasmic
nonreceptor mechanism of apoptosis that is induced by
proteins containing certain forms of the death-effector do-
main, and involves the formation of a striking cytoskeletal-
like protein assembly. Several observations allow us to
suggest how this type of programmed cell death occurs.
First, we find that DEDs from either FADD or caspase 8
can induce classic apoptosis that involves activation of
caspases, and can be blocked by the peptide inhibitor
zVAD-fmk for these proteases. Second, we find that apop-
tosis by these DED proteins is associated with the assem-
bly of these proteins into cytoplasmic filamentous struc-
tures that we have called DEFs. Third, DEFs are
detergent-insoluble, and do not correspond to other
known cellular structures. Fourth, we have shown that sol-
uble caspase-8 has the property of being recruited to the
DEF via its DED domains. Fifth, viral DED proteins that
prevent apoptosis do not form the DEF, and cause dissolu-
tion of the DEF formed by apoptosis-promoting DEDs.
Finally, although Bcl-x prevents this form of death, it does
not prevent DEF assembly, and therefore blocks a down-
stream or parallel step in the death pathway. Thus, we pro-
pose that DEF assembly leads to recruitment and activa-
tion of DED-containing caspases, and initiation of the
molecular cascade of apoptosis. Recruitment to the DEF
is highly efficient, and would cause a dramatic increase in
Figure 6. Viral DED-containing proteins are soluble, and do not
form filaments. (A) 0.5 mg of HA-tagged MC159 and E8 fusion
protein constructs were transfected into HeLa cells, and were
then analyzed by immunofluorescence 24 h later with anti-HA
mAb, followed by antimouse IgG Texas Red. Diffuse staining
above background can be seen with both MC159 and E8. (B)
Western blots: HA-tagged MC159 and E8 were transfected into
293T cells, and equivalent cell numbers from supernatants and
pellets of NP-40 lysates were analyzed by Western blotting with
anti-HA mAb.Siegel et al. Death-effector Filaments 1251
local concentration of procaspases, which in other systems
has resulted in autocatalytic processing and release of the
active enzyme into the cytoplasm. We have shown that
proximity-induced oligomerization of caspases is critical
for their activation (Martin et al., 1998). The DEVD-
rhodamine substrate used in these experiments primarily
measures Caspase-3/CPP32 activity, so our conclusions
about caspase-8 activation are based on indirect evidence
at this time. Nevertheless, the DEF represents a novel cy-
toplasmic protein assembly that has an essential role in
apoptosis caused by DEDs. Our findings suggest that as-
sembly of higher order structures enhances the efficiency
of caspase activation. This type of macromolecular assem-
bly may also play a role in the Fas death-signaling complex
Figure 7. Protection from
apoptosis by MC159, but not
Bcl-x, correlates with inhibi-
tion of DEF formation. (A)
In the left panels, Hela cells
were cotransfected with
Caspase-8–DED-AB–GFP and
HA-MC159, and were ana-
lyzed by anti-HA immuno-
fluorescence. A representa-
tive field is shown with
apoptotic cells with DEFs
transfected with Caspase-8
DED-AB alone (green) and
two viable cells in the upper
left that are cotransfected
with MC159 (red). Note the
shortening or disappearance
of the DEFs in the cotrans-
fected cells. Similar results
were obtained with FADD
WT and FADD DED
cotransfections. The right
panels show a representative
cell cotransfected with Bcl-x
(stained with anti-Bclx; red)
and Caspase-8 DED-AB
GFP. Note the preservation
of the filamentous pattern
with the DED-GFP. Similar
results were obtained with
FADD-GFP as well as Bcl-2.
(B) Quantitation of the pro-
tective effect of MC159 and
Bcl-x on DED-induced apop-
tosis. HeLa cells were
cotransfected with 0.5 mg of
the Caspase-8 DED GFP
construct, and 1.5 mg of
MC159 HA or P CMV Bcl-x.
16 h later, cells were har-
vested and fixed with formal-
dehyde, and apoptotic cells
were scored with an inverted
fluorescence microscope. At
least 100 cells/sample were
counted for each data point.
Percentages are the average
of two independently trans-
fected wells. Similar results
were obtained in two other
experiments.The Journal of Cell Biology, Volume 141, 1998 1252
at the membrane where the stoichiometry of the compo-
nents of the complex is not presently known.
Why cellular and not viral DED proteins aggregate into
apoptosis-inducing structures is not clear. Computer mod-
eling predicts that the DED domain folds into an alpha-
helix–rich structure, with some similarity to the Fas/CD95
death domain (Hofmann et al., 1997; Huang et al., 1996).
The fact that the full-length pro-caspase-8 protein contains
both DED domains but does not aggregate into filaments,
suggests that there may be major conformational differ-
ences between the DED fragment and the whole protein.
Posttranslational modification may also play a role in de-
termining the subcellular localization of DED-containing
proteins, as it does in other signaling systems. The spacer
region between the DED and caspase domains of caspase-8
(amino acids 178–210) is not homologous with the viral
FLIPs, and may also contain domains important in fila-
ment formation. Three-dimensional structures of DED
domains or unprocessed pro-caspases may shed light on
these differences in functional properties.
The DEF is one of several intracellular sites at which
apoptosis signaling is now known to be regulated. The fact
that Bcl-2 family proteins block DED-induced apoptosis
without blocking filament formation suggests that their
mechanism of action is downstream or in a parallel path-
way. Since Bcl-x has been shown to bind pro-caspase-8,
presumably through a ced-4–like adapter molecule (Chin-
naiyan et al., 1997), one possibility for its mechanism of ac-
tion may be the sequestration of procaspases to mitochon-
drial and internal cell membranes where Bcl-x is located.
However, in cotransfection experiments we did not find
significant colocalization of pro-caspase-8 with overex-
pressed Bcl-x or Bcl-2. Whether this result is due to insuffi-
cient quantities of adapter molecules, or to other require-
ments for such an interaction is not clear. Bcl-2 family
proteins also have been shown to inhibit release of pro-
apoptotic molecules such as cytochrome c from mitochon-
dria into the cytoplasm (Kluck et al., 1997; Yang et al.,
1997), and can also block apoptosis after release of cyto-
chrome c into the cytoplasm (Li et al., 1997; Rosse et al.,
1998). Through either of these pathways, Bcl-x could
block the downstream activation of the effector caspases
(which include caspase 3) without affecting Caspase-8 au-
toactivation or DEF formation.
Our data show that DEF formation is a regulated mech-
anism of apoptosis induction that might occur in various
physiological situations. The filaments are not dependent
on the transient transfection system, as 293T cells stably
expressing the caspase-8 DED filaments have been grown
in tissue culture for .3 mo (R.M. Siegel and M.J. Lenardo,
unpublished data). 293T cells are resistant to the proapop-
totic effects of the DEF, perhaps because of their expres-
sion of the adenovirus E1B19K protein. It is not clear at
this time whether DEFs are formed after Fas cross-linking.
It has been shown that caspase processing within the Fas
signaling complex causes release of the caspase 8 DEDs
into the cytoplasm (Medema et al., 1997). The released
prodomains could form a DEF, and amplify the death sig-
nal in the cytoplasm. However, preliminary experiments
with a caspase-8 construct tagged separately at the amino
and carboxy termini have thus far failed to show a filamen-
tous pattern of expression for the DED domain after Fas
cross-linking or staurosporine treatment. The concentra-
tion of apoptosis inhibitory proteins such as c-FLIP may
also regulate the threshold for filament formation by DED
proteins. The ability of viral proteins that block cell death
to disrupt the DEF suggests a role for these proteins in the
outcome of virus infection. It is also possible that the DEF
is the prototype for cytoplasmic assemblies that lead to
caspase activation and apoptosis induction under patho-
logical circumstances. Filament formation by normally sol-
uble proteins has been proposed as an important mecha-
nism in the pathogenesis of neurodegenerative diseases.
The paired helical filaments in Alzheimer’s disease and
the cytoplasmic aggregates formed by pathogenic prion
protein are composed of conformationally altered soluble
proteins, and have been reported to be involved in causing
apoptotic death of neurons (Forloni et al., 1993; LaFerla
et al., 1995). In light of our data, it will be important to de-
termine if formation of these filaments can also recruit or
activate caspases in the manner we have observed.
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